Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShepherd Neame Ltd Regulatory News (SHEP.PL)

Share Price Information for Shepherd Neame Ltd (SHEP.PL)

Share Price is delayed by 15 minutes
Get Live Data
507.50    0.00 (0.00%)
Bid:
505.00
Ask:
510.00
Spread: 5.00 (0.99%)
Market Cap: £74.95m
SHEP.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Shepherd Neame Ltd Share Chart

Transaction in Own Shares

21 Feb 2025 07:00

RNS Number : 9363X
Shepherd Neame Limited
21 February 2025
 

21 February 2025

Shepherd Neame Limited

Transaction in Own Shares

Shepherd Neame Limited (the "Company") announces that it has purchased for cancellation (through Peel Hunt LLP ("Peel Hunt") ordinary shares of 50p each in the Company ("Ordinary Shares") on the London Stock Exchange as follows:

Date of purchase:

20/02/2025

Number of shares purchased (aggregated volume):

9,355

Highest price paid per share (pence):

557.00p

Lowest price paid per share (pence):

557.00p

Volume weighted average price paid per share (pence):

557.00p

 

Following the purchase and cancellation of those shares, the Company will have 14,794,763 Ordinary Shares in issue. This figure 14,794,763 represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended), the table below contains detailed information of the individual trades made by Peel Hunt as part of the Company's share buyback programme on the date mentioned above.

Aggregate information: 

Venue

Volume-weighted average price (pence per share)

Aggregated volume

Aquis (AQSG)

557.00

9,355

Total

557.00

9,355

 Individual transactions:

Number of shares purchased

Transaction price (pence per share)

Venue

Time of transaction

Trade ID

5,355

557.00

AQSG

09:28:00

00173208291TRLO0

4,000

557.00

AQSG

16:24:26

00173254550TRLO0

 

For further information:

Shepherd Neame Limited

Tel: +44 (0)1795 532206

Richard Oldfield, Chairman

Jonathan Neame, Chief Executive

Peel Hunt LLP

Tel: +44 (0)20 7418 8900

Dan Webster

Andrew Clark

Instinctif Partners

Tel: +44 (0)20 7457 2020

Matthew Smallwood

Justine Warren

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXSEFFWSEISELE
12
Date   Source Headline
2nd Oct 20247:00 amRNSFinal results for the 53 weeks to 29 June 2024
27th Aug 20249:17 amRNSHolding(s) in Company
8th Jul 20243:15 pmRNSDirector/PDMR Shareholding
11th Jun 20245:10 pmRNSHolding(s) in Company
14th May 202411:47 amRNSDirector / PDMR Shareholding
10th Apr 202410:48 amRNSDirector / PDMR Shareholding
2nd Apr 202410:35 amRNSDirector / PDMR Shareholding
28th Mar 202411:55 amRNSDirector/PDMR Shareholding
26th Mar 20242:44 pmRNSDirector/PDMR Shareholding
22nd Mar 20243:46 pmRNSDirector/PDMR Shareholding
20th Mar 20248:52 amRNSInterim Results
2nd Nov 202312:19 pmRNSDirector/PDMR Shareholding
17th Oct 20235:44 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSPreliminary Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.